Avidex Limited And Active Biotech AB Release: RhuDex(R) Successfully Concludes Phase I Clinical Trials
Avidex will now be starting a dose-escalating, double blind pilot phase I/II study in rheumatoid arthritis (RA) patients. The study is designed to investigate safety, pharmacokinetics and drug interactions in patients and is expected to start recruitment beginning in mid 2006.